Ann: IHL initiates psilocybin clinical trial for anxiety disorder, page-26

as someone who is medicated depression is not covered . also meds are often prescribed off label. how big this could go is anyone's guess .

Strength of evidence matters more than presence or absence of a specific licence

In most countries, medicines have a product licence that describes how they should be used. Licensing is intended to ensure that medicines meet acceptable standards of efficacy, safety, and quality for a particular indication in a particular group of patients.1 “Off-label” use occurs when a drug is prescribed for an unlicensed indication, to an unlicensed patient group (such as children), and/or as an unlicensed dosage or formulation. In their paper (doi:10.1136/bmj.j603), Wong and colleagues found that almost a third of antidepressants were prescribed for off-label indications, most commonly pain, insomnia, and migraine.2